BioMed Realty Trust, Inc. 

(Public, NYSE:BMR)   Watch this stock   
Find more results forBMR
Feb 11, 2010
Q4 2009 Earnings Release - 12:00PM EST - Add to calendar
Oct 29, 2009
Q3 2009 Earnings Conference Call - Webcast
Oct 28, 2009
Q3 2009 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 9.05% 22.18%
Operating margin 31.30% 42.14%
EBITD margin - 70.03%
Return on average assets 1.02% 2.13%
Return on average equity 1.02% 3.75%
Employees 126 -

Address

17190 Bernardo Center Drive
San Diego, CA 92128
United States - Map
+1-858-4859840 (Phone)
+1-858-4859843 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

BioMed Realty Trust, Inc. discussed on blogs

BioMed Realty Trust, Inc. discussions

  View all discussions »

Description

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry. The Company’s tenants include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. As of December 31, 2008, the Company’s portfolio consisted of 69 properties, which included 112 buildings with an aggregate of approximately 10.4 million rentable square feet, including 1.4 million square feet of development in progress. The Company also owned undeveloped land parcels adjacent to its existing properties. The Company’s properties are in markets established as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey.

Officers and directors

Alan D. Gold
Chairman of the Board, Chief Executive Officer
Portrait Age: 48
Bio & Compensation - Reuters
R. Kent Griffin Jr.
President, Chief Financial Officer, Chief Operating Officer
Age: 39
Bio & Compensation - Reuters
Gary A. Kreitzer
Executive Vice President, General Counsel, Director
Age: 54
Bio & Compensation - Reuters
Matthew G. McDevitt
Executive Vice President - Acquisitions and Leasing
Age: 43
Bio & Compensation - Reuters
Barbara R. Cambon
Director
Age: 55
Bio & Compensation - Reuters
Edward A. Dennis Ph.D.
Director
Age: 67
Bio & Compensation - Reuters
Theodore D. Roth
Director
Age: 58
Bio & Compensation - Reuters
M. Faye Wilson
Director
Age: 71
Bio & Compensation - Reuters
Richard I. Gilchrist
Director
Age: 63
Bio & Compensation - Reuters